Research and Training
Chennai Breast Centre offer one-week training programs to young surgeons and radiologists, giving them the opportunity to gain insight into breast imaging and breast surgery.
Research
Institutional Ethics Committee
The Institutional Ethics Committee (IEC) of Chennai Breast Centre constituted in 2018, is recognized as a registered body by the Drug Controller General of India (DCGI) under the Central Drugs Standard Control Organization and by the Department of Health Research (DHR) under the National Ethics Committee Registry for Biomedical and Health Research (NECRBHR), Government of India.
The CBC IEC is headed by a Chairperson and supported by 12 other members including the Member Secretary. The composition of the IEC is a mix of members from different disciplines including medical doctors/clinicians, distinguished scientist, microbiologist, social scientist, pharmacologist, legal expert and lay persons.
Guided by Indian Council of Medical Research (ICMR) guidelines, the CBC IEC ensures a competent and objective review of all ethical aspects of the project proposals received by it. It strives to protect and promote the dignity, rights and well-being of potential research participants. It also makes sure that universal ethical values and international scientific standards are adhered to. The committee meets regularly to inform the members on any updates.
Breast Histopathology Laboratory with Tumour Banking Facility
A dedicated Breast Cancer Pathology Laboratory, along with a Biobanking facility, is available for the storage of FFPE (formalin-fixed, paraffin-embedded) tissue blocks, with all necessary permissions in place. These facilities play an important role in supporting research by preserving tissue samples for future studies. Such research can help improve understanding of breast cancer, contribute to the development of new treatments, and enhance the ability to predict outcomes, ultimately leading to better care for patients.
Add - Aspirin Trial
A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours.
In India, the trial has been approved by the Directorate of the National Cancer Grid (NCG), and is part of the NCG trials portfolio. University College London (UCL) and the Tata Memorial Centre (TMC) are co-sponsors of the trial and have delegated responsibility for the overall management of the Add-Aspirin trial to the MRC CTU at UCL and Tata Memorial Centre CTU for India.
Chennai Breast Centre is one of the centres participating in this Add Aspirin trial.
Training
One-Week Training Programs
We offer one-week training programs to young surgeons and radiologists, giving them the opportunity to gain insight into breast imaging and breast surgery at Chennai Breast Centre. The program allows them to assist with surgical procedures including oncoplastic procedures, sentinel lymph node biopsies. They are given the opportunity to observe the functioning of the one stop diagnostic facility where clinical examination, mammography, breast ultrasound and ultrasound guided interventions are performed.
Our in-house state-of-the-art conference room is equipped with an interactive display and advanced video transmission capabilities, enabling workshops and seminars to be conducted seamlessly for both in-person and virtual audiences.
